Literature DB >> 5171386

Thyrotoxicosis developing during cyclophosphamide therapy.

I R McDougall, W R Greig, H W Gray, J F Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5171386      PMCID: PMC1799552          DOI: 10.1136/bmj.4.5782.275

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA.

Authors:  J P KRISS; V PLESHAKOV; J R CHIEN
Journal:  J Clin Endocrinol Metab       Date:  1964-10       Impact factor: 5.958

2.  GLUCOCORTICOID-INDUCED DISAPPEARANCE OF LONG-ACTING THYROID STIMULATOR IN THE OPHTHALMOPATHY OF GRAVES' DISEASE.

Authors:  N J SNYDER; D E GREEN; D H SOLOMON
Journal:  J Clin Endocrinol Metab       Date:  1964-11       Impact factor: 5.958

3.  Increased thyroid function without clinical hyperthyroidism in patients with choriocarcinoma.

Authors:  W D ODELL; R W BATES; R S RIVLIN; M B LIPSETT; R HERTZ
Journal:  J Clin Endocrinol Metab       Date:  1963-07       Impact factor: 5.958

4.  The bioassay of thyrotropin in serum.

Authors:  J M McKENZIE
Journal:  Endocrinology       Date:  1958-09       Impact factor: 4.736

5.  Modification of thyroid activity in absence of the anterior pituitary gland.

Authors:  R C GOLDBERG; R O GREEP; L B NAY
Journal:  Proc Soc Exp Biol Med       Date:  1953-12

6.  Immunosuppressive therapy for the eye changes of Graves' disease.

Authors:  G N Burrow; M S Mitchell; R O Howard; L B Morrow
Journal:  J Clin Endocrinol Metab       Date:  1970-09       Impact factor: 5.958

7.  Graves' disease with delayed hyperthyroidism. Onset after several years of euthyroid ophthalmopathy, dermopathy, and high serum LATS.

Authors:  I J Chopra; D H Solomon
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

8.  Remission of hyperthyroidism (Graves' disease) and altered pattern of serum-thyroxine binding induced by prednisone.

Authors:  S C Werner; S R Platman
Journal:  Lancet       Date:  1965-10-16       Impact factor: 79.321

9.  Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.

Authors:  L M Lipman; D E Green; N J Snyder; J C Nelson; D H Solomon
Journal:  Am J Med       Date:  1967-10       Impact factor: 4.965

  9 in total
  1 in total

Review 1.  Drug-induced endocrine disorders.

Authors:  D Evered; P P Yeo
Journal:  Drugs       Date:  1977-05       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.